Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Workplace Policy topic
No spam. Unsubscribe anytime.
Panel backs bill to limit use of metabolite-only cannabis tests for adverse employment actions and require better impairment measures
Summary
The committee advanced House Bill 230, which would prevent employers from taking adverse actions based solely on cannabis metabolites and directs state agencies to develop or approve more accurate methods for assessing impairment for safety-sensitive positions.
The House Judiciary Committee voted to advance House Bill 230, which seeks to shield medical cannabis patients from adverse employment actions based solely on the presence of cannabis metabolites and to encourage adoption of impairment-assessment methods for safety-sensitive jobs.
Sponsor Representative (sponsor) said the measure is aimed at workers — including firefighters and veterans — who obtain medical cannabis under the Lynn and Erin Compassionate Use Act but face workplace drug-testing policies that rely on urine tests that detect metabolites from past use rather than current impairment. Miguel Tippman, representing firefighter and public-safety members, testified that members use medical cannabis off duty under physician direction for conditions including PTSD, chronic pain and sleep disorders. Tippman said current urine testing cannot reliably identify impairment and that the bill is intended to protect medically authorized use while keeping workplaces safe.
The bill directs the Department of Health and the Department of Workforce Solutions to develop or recognize standards to assess impairment — for example, drug-recognition-expert evaluations, validated psychomotor tests or point-of-contact oral fluid (cheek swab) tests approximating recent use. The sponsor’s amendment clarifies that evidence consisting solely of metabolites or components of cannabis without additional evidence of impairment would be inadmissible in adverse-employment actions.
Opponents raised concerns about safety-sensitive positions and federal requirements for some jobs (for example, certain firearm-bearing positions and commercial drivers). The chair and witnesses pointed to federal exemptions (e.g., some firefighter regulations) and to the bill’s explicit allowance for employers to act on reasonable suspicion or in post-accident investigations; the bill does not authorize on-duty cannabis use. After amendments removing the word “significant” from the property-damage standard and adding employer protections and impairment-definition language, the committee reported the bill with a do-pass recommendation.
